143 related articles for article (PubMed ID: 11836587)
1. Neovascularization in pancreatic ductal adenocarcinoma: Microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas.
Ueda T; Oda T; Kinoshita T; Konishi M; Nakahashi C; Takahashi S; Hasebe T; Fukao K; Ochiai A
Oncol Rep; 2002; 9(2):239-45. PubMed ID: 11836587
[TBL] [Abstract][Full Text] [Related]
2. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma.
Stipa F; Lucandri G; Limiti MR; Bartolucci P; Cavallini M; Di Carlo V; D'Amato A; Ribotta G; Stipa S
Anticancer Res; 2002; 22(1A):445-9. PubMed ID: 12017330
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
6. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T
Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of tumor vascularity in gastric carcinoma].
Tao H; Lin Y; Yin H; Wang R
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):307-9, 57. PubMed ID: 11825396
[TBL] [Abstract][Full Text] [Related]
9. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
11. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
[TBL] [Abstract][Full Text] [Related]
14. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats].
Liang S; Yang ZL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598
[TBL] [Abstract][Full Text] [Related]
15. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
16. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
[TBL] [Abstract][Full Text] [Related]
17. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities.
Kawai M; Uchiyama K; Tani M; Onishi H; Kinoshita H; Ueno M; Hama T; Yamaue H
Arch Surg; 2004 Feb; 139(2):188-92. PubMed ID: 14769579
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CXCL12-CXCR4 and its association with angiogenesis in pancreatic cancer].
Niu ZX; Fei LM; Wang CL
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):286-7. PubMed ID: 19615285
[No Abstract] [Full Text] [Related]
20. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
